Table 2 Correlations between age, clinical, and spectroscopic data in patients with AD
From: Value of magnetic resonance spectroscopy in geriatric patients with cognitive impairment
Age in years | GDS | MoCA | ||
|---|---|---|---|---|
Hippo NAA | Pearson correlation | .184 | −.019 | .710 |
Significance | .438 | .937 | .000 | |
Hippo Cr. | Pearson correlation | −.351 | −.319 | .095 |
Significance | .129 | .170 | .689 | |
Hippo NAA/Cr | Pearson correlation | .359 | .143 | .599 |
Significance | .120 | .548 | .005 | |
Frontal NAA | Pearson correlation | .195 | .060 | .325 |
Significance | .411 | .802 | .162 | |
Frontal Cr. | Pearson correlation | −.031 | .140 | −.010 |
Significance | .898 | .556 | .968 | |
Frontal NAA/Cr | Pearson correlation | .204 | .018 | .317 |
Significance | .388 | .940 | .173 | |